Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Novo Nordisk A/S (NOVOB)?s oral insulin successfully completed an early-stage study, according to the Danish drugmaker?s partner, Merrion Pharmaceuticals Plc (MERR), bringing what would be the first product of its kind a step closer to market.
The goals of the clinical trial, the first of three phases of human testing usually required by regulators for marketing approval, were to test the insulin tablet?s safety, tolerability, exposure and effect on blood-sugar levels, Dublin- based Merrion said today in a statement.
http://www.bloomberg.com/news/2013-...sulin-successfully-completes-early-study.html
The goals of the clinical trial, the first of three phases of human testing usually required by regulators for marketing approval, were to test the insulin tablet?s safety, tolerability, exposure and effect on blood-sugar levels, Dublin- based Merrion said today in a statement.
http://www.bloomberg.com/news/2013-...sulin-successfully-completes-early-study.html